Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001104659-25-006784

Director acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Aggarwal Sumit · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-24 Exercise or conversion : show line 1 in the form +30,000 199,930 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-24 Exercise or conversion : show line 2 in the form Restricted Stock Units −30,000 30,000 D
Loading xslF345X05/tm254730-4_4seq1.xml…